VivoSeq
Other

Loneliness

1

Pipeline Programs↗

3

Active Trials↗

2

Companies Involved↗

Loneliness is an early-stage landscape with 1 program across 2 companies. The most active players are COMPASS Pathways, Eli Lilly.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

15/100

Mech. Concentration

100/100

Completion Rate

N/A

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

COMPASS Pathways logo

COMPASS Pathways

1 program

Phase 1Eli Lilly logo

Eli Lilly

1 program

Phase 1

Pipeline

Programs by Phase

Preclinical
No programs
Phase 11

Psilocybin

COMPASS Pathways

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

3

clinical trials

Recruiting2 · 67%
Not yet recruiting1 · 33%

Clinical Trials

Trial Activity

The Effects of Psilocybin on Social Connectedness
Not yet recruiting·YYale University·Phase 1·NCT07693153·51 enrolled
BabaCare: Testing a Care Copilot
Recruiting·JJohns Hopkins University·Preclinical·NCT07689526·40 enrolled
Alleviating Loneliness in Older Adults Living in Poverty: A Multi-level Intervention
Recruiting·EEducation University of Hong Kong·Preclinical·NCT07123064·1,344 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)